Financials
Financial year 2024
SELVIPHARMA from Brussel, company number BE0635925961, closed financial year 2024 with a result of € 6,068 after tax. For that financial year SELVIPHARMA recorded a gross margin of € 70,379 and equity of € 42,606. Compared with financial year 2023, the result moved from € 12,407 to € 6,068. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 27, 2025.
€ 42,606
▲ 17% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,068
▼ 51% vs 2023
Profit after tax over the fiscal year.
€ 92,996
▼ 1% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 24,006.
People and assets in 2024
€ 51,744
▲ 24% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 18,322
▼ 55% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 48,805
▲ 15% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 62,876 | € 68,241 | € 68,515 | € 70,379 | ▲ 3% |
| Profit after taxes | € 749 | € 7,075 | € 12,407 | € 6,068 | ▼ 51% |
| Equity | € 17,056 | € 24,131 | € 36,538 | € 42,606 | ▲ 17% |
| Total debts | € 75,581 | € 118,400 | € 84,208 | € 67,127 | ▼ 20% |
| Cash | € 41,072 | € 64,772 | € 94,169 | € 92,996 | ▼ 1% |
| Retained profit | € -1,544 | € 5,531 | € 17,938 | € 24,006 | ▲ 34% |
| Balance sheet total | € 92,637 | € 142,531 | € 120,746 | € 109,734 | ▼ 9% |
Key figures of SELVIPHARMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to SELVIPHARMA?
What happened at SELVIPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 6,068 (▼ 51% vs 2023). filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
- Ahmet Gursever became a director. NBB
- Selvihan Beklevic became a director. NBB
In short
From € 749 profit in 2021 to € 6,068 profit in 2024.
Paid € 15,760 in corporate taxes since 2021.
Best year ever: 2023, with € 12,407 profit.
A new publication or filing at SELVIPHARMA? We notify you, reason included.
Follow SELVIPHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SELVIPHARMA are Ahmet Gursever and Selvihan Beklevic .
Directors
According to the 2024 annual accounts
Ahmet Gursever
Director
since 2015
Selvihan Beklevic
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Anderlechtsesteenweg 36
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0635.925.961
- VAT number
- BE 0635.925.961
- Registered office
- Anderlechtsesteenweg 36, 1000 Brussel
- Names & denominations
- SELVIPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 September 2015
- Peppol
- Active · Active since 1 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten